We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Rectal Suppository Applicator Improves Therapeutic Efficiency

By HospiMedica International staff writers
Posted on 13 May 2014
A novel applicator offers a dramatic improvement in the quality of life to the millions of people who require suppository medication therapy. More...


The Sephure disposable suppository applicator is an anatomically designed device intended for patients prescribed rectal suppository medication. Using the applicator, patients can quickly, hygienically, and comfortably administer rectal suppositories. The inner structure of the applicator has vents to allow air to exit the body during administration and withdrawal of the applicator into the rectum. The applicator also positions suppositories further into the rectum, away from the nerves that signal the body to expel the contents of the bowel. The device comes in two sizes to fit the most common suppository shapes.

Suppository medication is designed to melt at body temperature; as a result, when the medication has melted and the trapped air is expelled from the body, the medication leaks. By allowing the air to escape, the Sephure applicator eliminates suction effect, leaving the suppository properly placed away from the nerve endings that signal the body to expel the contents of the bowel. As a result, the person does not feel the medication while it melts and is absorbed by the body, and the feeling of urgency to expel the medication is eliminated. When used for administering a laxative suppository, better contact with the lining of the rectum results in a better end result.

The Sephure disposable suppository applicator was designed by Jennifer Davagian Ensign, who was diagnosed with Inflammatory Bowel Disease (IBD) more than 20 years ago and lived with infrequent flares. Depositing a suppository dose took her 30–45 minutes lying in the prone position, inserting the suppository with her finger, and resisting the urgency to release the medication. Upon standing, she needed to wear protective undergarments since the medicine leaked outside the body. Within a few months the regimen became too burdensome and she abandoned her treatment; a serious health scare then led her to create the device.

“At first it was difficult talking about something so private in a public forum,” said Ensign, who is also the CEO of Cristcot (Concord, MA, USA), the company she founded to manufacture the Sephure applicator. “By telling my story I hope to create a new standard of care and in the process, improve the quality of life of others who struggle with the difficulties of suppository treatment.”

Related Links:

Cristcot



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.